These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 2075440)
1. New labels; their importance in current and future immunoassays. Sand T Scand J Clin Lab Invest Suppl; 1990; 202():32-5. PubMed ID: 2075440 [No Abstract] [Full Text] [Related]
2. High specific activity chemiluminescent and fluorescent markers: their potential application to high sensitivity and 'multi-analyte' immunoassays. Ekins R; Chu F; Micallef J J Biolumin Chemilumin; 1989 Jul; 4(1):59-78. PubMed ID: 2801243 [TBL] [Abstract][Full Text] [Related]
3. A selected history and future of immunoassay development and applications in clinical chemistry. Wu AH Clin Chim Acta; 2006 Jul; 369(2):119-24. PubMed ID: 16701599 [TBL] [Abstract][Full Text] [Related]
5. How alternative are immunoassay systems employing non-radioisotopic labels? A comparative appraisal of their main analytical characteristics. Pelizzola D; Bombardieri E; Brocchi A; Cappelli G; Coli A; Federghini M; Giganti M; Gion M; Madeddu G; Maussieri ML Q J Nucl Med; 1995 Dec; 39(4):251-63. PubMed ID: 8624786 [TBL] [Abstract][Full Text] [Related]
7. Immunoassays: a roadmap for the 1980s. Eby WC; Berk LS Am J Med Technol; 1982 Aug; 48(8):645-50. PubMed ID: 6753579 [TBL] [Abstract][Full Text] [Related]
8. Immunoassay labels based on chemiluminescence and bioluminescence. Seitz WR Clin Biochem; 1984 Apr; 17(2):120-5. PubMed ID: 6375893 [TBL] [Abstract][Full Text] [Related]
10. Bioluminescent enzyme immunoassay for progesterone using monoclonal antibodies and glucose-6-phosphate dehydrogenase labels. Brochu M; Carrié ML; Térouanne B; Bélanger A; Nicolas JC J Biolumin Chemilumin; 1987 Sep; 1(4):215-22. PubMed ID: 3332551 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and properties of new luminescent acridinium-9-carboxylic acid derivatives and their application in luminescence immunoassays (LIA). Kinkel T; Lübbers H; Schmidt E; Molz P; Skrzipczyk HJ J Biolumin Chemilumin; 1989 Jul; 4(1):136-9. PubMed ID: 2801207 [TBL] [Abstract][Full Text] [Related]
12. Configuration and optimization of a common two-site immunoassay for human prolactin using a chemiluminescent tracer and an enzymatic tracer. Farina L; Comuzio S; Bolelli G; Mimmi P; Messeri G; Orlandini A J Biolumin Chemilumin; 1989 Jul; 4(1):587-93. PubMed ID: 2678928 [TBL] [Abstract][Full Text] [Related]
13. [Chemi- and bio-luminescent immunoassay]. Maeda M; Tsuji A Nihon Rinsho; 1995 Feb; 53 Su Pt 1():77-83. PubMed ID: 8753382 [No Abstract] [Full Text] [Related]
14. Novel poly-substituted aryl acridinium esters and their use in immunoassay. Law SJ; Miller T; Piran U; Klukas C; Chang S; Unger J J Biolumin Chemilumin; 1989 Jul; 4(1):88-98. PubMed ID: 2801251 [TBL] [Abstract][Full Text] [Related]
15. [I. Principles and applications of immunoassay: luminescence immunoassay]. Tsuji A; Maeda M Rinsho Byori; 1983 Feb; Suppl 53():61-70. PubMed ID: 6223159 [No Abstract] [Full Text] [Related]
16. Immunology: current and future technology assessment. Maggio ET; Nakamura RM Clin Lab Med; 1981 Mar; 1(1):77-109. PubMed ID: 7049515 [No Abstract] [Full Text] [Related]
17. [Biotechnology and clinical biology]. Ann Biol Clin (Paris); 1985; 43(4):493-517. PubMed ID: 3911826 [TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies, antigens and molecular diagnostics: a practical overview. Laurino JP; Shi Q; Ge J Ann Clin Lab Sci; 1999; 29(3):158-66. PubMed ID: 10440578 [TBL] [Abstract][Full Text] [Related]